Royalty Pharma plcRPRXNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank80
3Y CAGR+6.4%
5Y CAGR+7.3%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+6.4%/yr
vs +4.8%/yr prior
5Y CAGR
+7.3%/yr
Consistent
Acceleration
+1.6pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.92% | -38.7% |
| 2024 | 24.34% | +2.4% |
| 2023 | 23.76% | +91.8% |
| 2022 | 12.39% | +1.5% |
| 2021 | 12.21% | +16.5% |
| 2020 | 10.47% | -1.0% |
| 2019 | 10.58% | +3.0% |
| 2018 | 10.27% | +14.1% |
| 2017 | 9.00% | - |
| 2016 | 0.00% | - |